Novel strategies and tools for enhanced sensitivity in routine biomolecule analytics

Current Pharmaceutical Analysis

Volumn 5, Issue 4, 2009, Pages 390-407

  Adler, Michael ^a   Spengler, Mark ^a  

^a CHIMERA BIOTEC GMBH   (Germany)

Author keywords

Biomarker analysis; ELISA; Immuno PCR; Pharmacokinetics; Polyplex; Sensitivity

Indexed keywords

BIOLOGICAL MARKER; BIOMATERIAL; DRUG;

CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; IMMUNOGENICITY; INTERMETHOD COMPARISON; MOLECULAR INTERACTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; TOXICOKINETICS;

EID: 75149163554     PISSN: 15734129     EISSN: None     Source Type: Journal    
DOI: 10.2174/157341209789649104     Document Type: Review

References (145)

1. Mullis, K.B.; Faloona, F. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol., 1987, 155, 335-350.
2. Edwards, M.C.; Gibbs, R.A. Multiplex PCR: advantages, development, and applications. PCR Methods Appl., 1994, 3, S65-S75.
3. Heid, C.A.; Stevens, J.; Livak, K.J.; Williams, P.M. Real time quantitative PCR. Genome Res., 1996, 6, 986-994.
4. Arya, M.; Shergill, I.S.; Williamson, M.; Gommersall, L.; Arya, N.; Patel, H.R. Basic principles of real-time quantitative PCR. Expert Rev. Mol. Diagn., 2005, 5, 209-219.
5. Kubista, M.; Andrade, J.M.; Bengtsson, M.; Forootan, A.; Jonak, J.; Lind, K.; Sindelka, R.; Sjoback, R.; Sjogreen, B.; Strombom, L.; Stahlberg, A.; Zoric, N. The real-time polymerase chain reaction. Mol. Aspects Med., 2006, 27, 95-125.
6. Comley, J. qPCR assays - end user practices and latest vendor offerings. Drug Discovery World, 2009, 10, 45-66.
7. Sano, T.; Smith, C.L.; Cantor, C.R. Immuno-PCR: very sensitive antigen detection by means of specific antibody-DNA conjugates. Science, 1992, 258, 120-122.
8. Swanson, J. The Rise of ImmunoPCR. Genome Technol., 2007, 23-26, Available at: http://www.genomeweb.com/rise-immunopcr
9. Adler, M.; Wacker, R.; Niemeyer, C.M. Sensitivity by combination: immuno-PCR and related technologies. Analyst, 2008, 133, 702-718.
10. Adler, M. In Frontiers in Nanoscience and Nanotechnology, A. Narlikar, ed.; OUP: Oxford, 2009; Vol. 2 - Properties and Potential of Protein-DNA Conjugates for Analytic Applications.
11. Niemeyer, C.M.; Adler, M.; Wacker, R. Immuno-PCR: high sensitivity detection of proteins by nucleic acid amplification. Trends Biotechnol., 2005, 23, 208-216.
12. Niemeyer, C.M.; Boldt, L.; Ceyhan, B.; Blohm, D. DNA-Directed Immobilization: Efficient, Reversible and Site-Selective Surface Binding of Proteins by Means of Covalent DNA-Streptavidin Conjugates. Anal. Biochem., 1999, 268, 54-63.
13. Wacker, R.; Niemeyer, C.M. DDI-microFIA - A readily configurable microarray-fluorescence immunoassay based on DNAdirected immobilization of proteins. Chembiochem., 2004, 5, 453-459.
14. Niemeyer, C.M.; Adler, M.; Gao, S.; Chi, L. Nanostructured dnaprotein aggregates consisting of covalent oligonucleotidestreptavidin conjugates. Bioconjug. Chem., 2001, 12, 364-371.
15. Joerger, R.D.; Truby, T. M.; Hendrickson, E.R.; Young, R.M.; Ebersole, R.C. Analyte detection with DNA-labeled antibodies and polymerase chain reaction. Clin. Chem., 1995, 41, 1371-1377.
16. Hendrickson, E.R.; Hatfield Truby, T.M.; Joerger, R.D.; Majarian, W.R.; Ebersole, R.C. High Sensitivity Multianalyte Immunoassay Using Covalent DNA-Labeled Antibodies and Polymerase Chain Reaktion. Nucleic Acids Res., 1995, 23, 522-529.
17. Zhang, H.T.; Kacharmina, J.E.; Miyashiro, K.; Greene, M.I.; Eberwine, J. Protein quantification from complex protein mixtures using a proteomics methodology with single-cell resolution. Proc. Natl. Acad. Sci. USA, 2001, 98, 5497-5502.
18. White, S.R.; Chiu, N.H.; Christopoulos, T.K. Expression immunoassay based on antibodies labeled with a deoxyribonucleic acid fragment encoding the alpha-peptide of beta- galactosidase. Analyst, 1998, 123, 1309-1314.
19. Chiu, N. H.; Christopoulos, T. K. Two-site expression immunoassay using a firefly luciferase-coding DNA label. Clin. Chem., 1999, 45, 1954-1959.
20. Christopoulos, T.K.; Chiu, N.H. Expression immunoassay. Antigen quantitation using antibodies labeled with enzyme-coding DNA fragments. Anal. Chem., 1995, 67, 4290-4294.
21. White, S.R.; Chiu, N.H.; Christopoulos, T.K. Expression immunoassay. Methods, 2000, 22, 24-32.
22. Crowther, J.R. ELISA; Theory and Practice, Humana Press Inc.: Totowa, New Jersey 1995.
23. Principles and Practise of Immunoassay, Macmillan Reference Ltd 1997.
24. Raem, A.M.; Rauch, P. Immunoassays, ELSEVIER Spektrum Akademischer Verlag: Munich 2007.
25. Adler, M. Immuno-PCR as a clinical laboratory tool. Adv. Clin. Chem., 2005, 39, 239-292.
26. Schiavo, S.; El-Shafey, A.; Jordan, N.; Orazine, C.; Wang, W.; Zhou, X.; Chiu, N.H.; Krull, I.S. Pushing the limits of detection with Immuno-PCR. PharmaGenomics, 2004, 36-45.
27. Zhang, H.; Zhao, Q.; Li, X. F.; Le, X.C. Ultrasensitive assays for proteins. Analyst, 2007, 132, 724-737.
28. Zhou, H.; Fisher, R.J.; Papas, T.S. Universal immuno-PCR for ultra-sensitive target protein detection. Nucleic Acids Res., 1993, 21, 6038-6039.
29. Griswold, W.R. Theoretical analysis of the sensitivity of the solid phase antibody assay(ELISA). Mol. Immunol., 1987, 24, 1291-1294.
30. Adler, M.; Schulz, S.; Fischer, R.; Niemeyer, C.M. Detection of Rotavirus from stool samples using a standardized immuno-PCR ("Imperacer") method with end-point and real-time detection. Biochem. Biophys. Res. Commun., 2005, 333, 1289-1294.
31. Barletta, J.; Bartolome, A.; Constantine, N. T. Immunomagnetic quantitative immuno-PCR for detection of less than one HIV-1 virion. J. Virol. Methods, 2009, 157, 122-132.
32. McElhinny, A.S.; Exley, G.E.; Warner, C.M. Painting Qa-2 onto Ped slow preimplantation embryos increases the rate of cleavage. Am. J. Reprod. Immunol., 2000, 44, 52-58.
33. McElhinny, A.S.; Kadow, N.; Warner, C.M. The expression pattern of the Qa-2 antigen in mouse preimplantation embryos and its correlation with the Ped gene phenotype. Mol. Hum. Reprod., 1998, 4, 966-971.
34. Adler, M.; Schulz, S.; Spengler, M. Cytokine Quantification in Drug Development: A comparison of sensitive immunoassay platforms. 2009, Available at: http://www.bionity.com/articles/e/100005/
35. Schoffski, P.; Riggert, S.; Fumoleau, P.; Campone, M.; Bolte, O.; Marreaud, S.; Lacombe, D.; Baron, B.; Herold, M.; Zwierzina, H.; Wilhelm-Ogunbiyi, K.; Lentzen, H.; Twelves, C. Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group. Ann. Oncol., 2004, 15, 1816-1824.
36. Goluch, E.D.; Nam, J.M.; Georganopoulou, D.G.; Chiesl, T.N.; Shaikh, K.A.; Ryu, K.S.; Barron, A.E.; Mirkin, C.A.; Liu, C.A. Bio-barcode assay for on-chip attomolar-sensitivity protein detection. Lab. Chip., 2006, 6, 1293-1299.
37. Adler, M.; N.N. Controlled Expression and Monitoring of HIV p66 / pol Protein in Cell Culture Samples. Manuscript in preparation, 2009.
38. Diel, P.; Schiffer, T.; Geisler, S.; Hertrampf, T.; Schulz, S.; Wintgens, K.F.; Adler, M. Detection of myostatin propeptide and follistatin in serum and tissue using highly sensitive Immuno PCR - effects of training and skeletal muscle mass. J. Appl. Physiol., 2009, in press.
39. Adler, M.; Wacker, R.; Niemeyer, C.M. A real-time immuno-PCR assay for routine ultrasensitive quantification of proteins. Biochem. Biophys. Res. Commun., 2003, 308, 240-250.
40. Spengler, M.; Adler, M.; Jonas, A.; Niemeyer, C.M. Immuno-PCR-assays for immunogenicity testing. Biochem. Biophys. Res. Commun., 2009, 387, 278-282.
41. Guo, Y.C.; Zhou, Y.F.; Zhang, X.E.; Zhang, Z.P.; Qiao, Y.M.; Bi, L.J.; Wen, J.K.; Liang, M.F.; Zhang, J.B. Phage display mediated immuno-PCR. Nucleic Acids Res., 2006, 34, e62.
42. Soderberg, O.; Leuchowius, K.J.; Kamali-Moghaddam, M.; Jarvius, M.; Gustafsdottir, S.; Schallmeiner, E.; Gullberg, M.; Jarvius, J.; Landegren, U. Proximity ligation: a specific and versatile tool for the proteomic era. Genet. Eng. (NY), 2007, 28, 85-93.
43. Gustafsdottir, S.M.; Schallmeiner, E.; Fredriksson, S.; Gullberg, M.; Soderberg, O.; Jarvius, M.; Jarvius, J.; Howell, M.; Landegren, U. Proximity ligation assays for sensitive and specific protein analyses. Anal. Biochem., 2005, 345, 2-9.
44. Fredriksson, S.; Gullberg, M.; Jarvius, J.; Olsson, C.; Pietras, K.; Gustafsdottir, S.M.; Ostman, A.; Landegren, U. Protein detection using proximity-dependent DNA ligation assays. Nat. Biotechnol., 2002, 20, 473-477.
45. Zhu, L.; Koistinen, H.; Wu, P.; Narvanen, A.; Schallmeiner, E.; Fredriksson, S.; Landegren, U.; Stenman, U.H. A sensitive proximity ligation assay for active PSA. Biol. Chem., 2006, 387, 769-772.
46. Gullberg, M.; Fredriksson, S.; Taussig, M.; Jarvius, J.; Gustafsdottir, S.; Landegren, U. A sense of closeness: protein detection by proximity ligation. Curr. Opin. Biotechnol., 2003, 14, 82-86.
47. Soderberg, O.; Gullberg, M.; Jarvius, M.; Ridderstrale, K.; Leuchowius, K.J.; Jarvius, J.; Wester, K.; Hydbring, P.; Bahram, F.; Larsson, L.G.; Landegren, U. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods, 2006, 3, 995-1000.
48. Niemeyer, C.M.; Wacker, R.; Adler, M. Hapten-Functionalized DNA-Streptavidin Nanocircles as Supramolecular Reagents in a Novel Competitive Immuno-PCR. Angew Chem. Int. Ed., 2001, 40, 3169-3172.
49. Adler, M.; Wacker, R.; Booltink, E.; Manz, B.; Niemeyer, C.M. Detection of femtogram amounts of biogenic amines using self-assembled DNA-protein nanostructures. Nat. Methods, 2005, 2, 147-149.
50. Zhou, C.; Wang, Q.E.; Zhuang, H.S. Determination of phenanthrene by antibody-coated competitive real-time immuno-PCR assay. Anal. Bioanal. Chem., 2008, 391, 2857-2863.
51. New FACTT technique is conservatively over 1000-times more sensitive than ELISA. Cancer Biol. Ther., 2006, 5, 346-348.
52. Zhang, Z.; Irie, R.F.; Chi, D.D.; Hoon, D.S. Cellular immuno-PCR. Detection of a carbohydrate tumor marker. Am. J. Pathol., 1998, 152, 1427-1432.
53. Adler, M.; Schulz, S.; Wacker, R. High-Sensitivity Detection of Prostate Specific Antigen. Am. Biotechnol. Lab., 2006, 24, 17.
54. Lind, K.; Kubista, M. Development and evaluation of three realtime immuno-PCR assemblages for quantification of PSA. J. Immunol. Methods, 2005, 304, 107-116.
55. Tian, P.; Mandrell, R. Detection of norovirus capsid proteins in faecal and food samples by a real time immuno-PCR method. J. Appl. Microbiol., 2006, 100, 564-574.
56. Wacker, R.; Ceyhan, B.; Alhorn, P.; Schueler, D.; Lang, C.; Niemeyer, C. M. Magneto immuno-PCR: a novel immunoassay based on biogenic magnetosome nanoparticles. Biochem. Biophys. Res. Commun., 2007, 357, 391-396.
57. Maia, M.; Takahashi, H.; Adler, K.; Garlick, R.K.; Wands, J.R. Development of a two-site immuno-PCR assay for hepatitis B surface antigen. J. Virol. Methods, 1995, 52, 273-286.
58. Niemeyer, C.M.; Adler, M.; Blohm, D. Fluorometric Polymerase Chain Reaction (PCR) Enzyme-Linked Immunosorbent Assay for Quantification of Immuno-PCR Products in Microplates. Anal. Biochem., 1997, 246, 140-145.
59. Barletta, J. Applications of real-time immuno-polymerase chain reaction (rt-IPCR) for the rapid diagnoses of viral antigens and pathologic proteins. Mol. Aspects Med., 2006, 27, 224-253.
60. Barletta, J.M.; Edelman, D.C.; Constantine, N.T. Lowering the detection limits of HIV-1 viral load using real-time immuno-PCR for HIV-1 p24 antigen. Am. J. Clin. Pathol., 2004, 122, 20-27.
61. McKie, A.; Samuel, D.; Cohen, B.; Saunders, N.A. Development of a quantitative immuno-PCR assay and its use to detect mumpsspecific IgG in serum. J. Immunol. Methods, 2002, 261, 167-175.
62. Zhang, W.; Bielaszewska, M.; Pulz, M.; Becker, K.; Friedrich, A.W.; Karch, H.; Kuczius, T. New immuno-PCR assay for detection of low concentrations of shiga toxin 2 and its variants. J. Clin. Microbiol., 2008, 46, 1292-1297.
63. Fischer, A.; von Eiff, C.; Kuczius, T.; Omoe, K.; Peters, G.; Becker, K. A quantitative real-time immuno-PCR approach for detection of staphylococcal enterotoxins. J. Mol. Med., 2007, 85, 461-469.
64. Allen, R.C.; Rogelj, S.; Cordova, S.E.; Kieft, T.L. An immuno-PCR method for detecting Bacillus thuringiensis Cry1Ac toxin. J. Immunol. Methods, 2006, 308, 109-115.
65. Wu, H.C.; Huang, Y.L.; Lai, S.C.; Huang, Y.Y.; Shaio, M.F. Detection of Clostridium botulinum neurotoxin type A using immuno-PCR. Lett. Appl. Microbiol., 2001, 32, 321-325.
66. Chao, H.Y.; Wang, Y.C.; Tang, S.S.; Liu, H.W. A highly sensitive immuno-polymerase chain reaction assay for Clostridium botulinum neurotoxin type A. Toxicon, 2004, 43, 27-34.
67. Gustafsdottir, S.M.; Nordengrahn, A.; Fredriksson, S.; Wallgren, P.; Rivera, E.; Schallmeiner, E.; Merza, M.; Landegren, U. Detection of individual microbial pathogens by proximity ligation. Clin. Chem., 2006, 52, 1152-1160.
68. Sanna, P.P.; Weiss, F.; Samson, M.E.; Bloom, F.E.; Pich, E.M. Rapid induction of tumor necrosis factor alpha in the cerebrospinal fluid after intracerebroventricular injection of lipopolysaccharide revealed by a sensitive capture immuno-PCR assay. Proc. Natl. Acad. Sci. USA, 1995, 92, 272-275.
69. Saito, K.; Kobayashi, D.; Sasaki, M.; Araake, H.; Kida, T.; Yagihashi, A.; Yajima, T.; Kameshima, H.; Watanabe, N. Detection of human serum tumor necrosis factor-alpha in healthy donors, using a highly sensitive immuno-PCR assay. Clin. Chem., 1999, 45, 665-669.
70. Komatsu, M.; Kobayashi, D.; Saito, K.; Furuya, D.; Yagihashi, A.; Araake, H.; Tsuji, N.; Sakamaki, S.; Niitsu, Y.; Watanabe, N. Tumor necrosis factor-alpha in serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR. Clin. Chem., 2001, 47, 1297-1301.
71. Gullberg, M.; Gustafsdottir, S.M.; Schallmeiner, E.; Jarvius, J.; Bjarnegard, M.; Betsholtz, C.; Landegren, U.; Fredriksson, S. Cytokine detection by antibody-based proximity ligation. Proc. Natl. Acad. Sci. USA, 2004, 101, 8420-8424.
72. Nam, J.M.; Wise, A.R.; Groves, J.T. Colorimetric bio-barcode amplification assay for cytokines. Anal. Chem., 2005, 77, 6985-6988.
73. Mullenix, M.; Dondero, R.; Hirock, D.; Egholm, M.; Kingsmore, S.; Perlee, L. In DNA Amplification - current technologies and applications, V.V.; Broude Demidov, N.E., ed.; Horizon Bioscience: Norfolk, 2004; Chapter 4.2., 313-331.
74. Adler, M.; Eisenbraun, J. In Die Mistel in der Tumortherapie, Scheer R., ed.; KVC Verlag: Essen, 2009; Vol. 2, 110-120.
75. Huber, R.; Eisenbraun, J.; Miletzki, B.; Adler, M.; Gleiter, C. Pharmacokinetics of mistletoe lectins - a phase I study. Phytomedicine, 2007, 14, 30.
76. Adler, M.; Eisenbraun, J. Immuno-PCR - highly sensitive protein detection: Results of the detection of native mistletoe lectin in human serum samples. Phytomedicine, 2007, 14, 50.
77. Schoffski, P.; Breidenbach, I.; Krauter, J.; Bolte, O.; Stadler, M.; Ganser, A.; Wilhelm-Ogunbiyi, K.; Lentzen, H. Weekly 24 h infusion of aviscumine (rViscumin): a phase I study in patients with solid tumours. Eur. J. Cancer, 2005, 41, 1431-1438.
78. Adler, M.; Langer, M.; Witthohn, K.; Wilhelm-Ogunbiyi, K.; Schoffski, P.; Fumoleau, P.; Niemeyer, C.M. Adaptation and performance of an immuno-PCR assay for the quantification of Aviscumine in patient plasma samples. J. Pharm. Biomed. Anal., 2005, 39, 972-982.
79. Adler, M.; Langer, M.; Witthohn, K.; Eck, J.; Blohm, D.; Niemeyer, C.M. Detection of rViscumin in plasma samples by immuno-PCR. Biochem. Biophys. Res. Commun., 2003, 300, 757-763.
80. McKie, A.; Samuel, D.; Cohen, B.; Saunders, N. A. A quantitative immuno-PCR assay for the detection of mumps-specific IgG. J. Immunol. Methods, 2002, 270, 135-141.
81. Barletta, J.M.; Edelman, D.C.; Highsmith, W.E.; Constantine, N.T. Detection of ultra-low levels of pathologic prion protein in scrapie infected hamster brain homogenates using real-time immuno-PCR. J. Virol. Methods, 2005, 127, 154-164.
82. Niemeyer, C.M.; Adler, M.; Wacker, R. Detecting antigens by quantitative immuno-PCR. Nat. Protoc., 2007, 2, 1918-1930.
83. Diamandis, E.P.; Christopoulos, T.K. The biotin-(strept)avidin system: principles and applications in biotechnology. Clin. Chem., 1991, 37, 625-636.
84. McElhinny, A.S.; Warner, C.M. Detection of major histocompatibility complex class I antigens on the surface of a single murine blastocyst by immuno-PCR. Biotechniques, 1997, 23, 660-662.
85. Case, M.; Major, G.N.; Bassendine, M.F.; Burt, A.D. The universality of immuno-PCR for ultrasensitive antigen detection. Biochem. Soc. Trans., 1997, 25, 374S.
86. Case, M.C.; Burt, A.D.; Hughes, J.; Palmer, J.M.; Collier, J.D.; Bassendine, M.F.; Yeaman, S.J.; Hughes, M.A.; Major, G.N. Enhanced ultrasensitive detection of structurally diverse antigens using a single immuno-PCR assay protocol. J. Immunol. Methods, 1999, 223, 93-106.
87. Sugawara, K.; Kobayashi, D.; Saito, K.; Furuya, D.; Araake, H.; Yagihashi, A.; Yajima, T.; Hosoda, K.; Kamimura, T.; Watanabe, N. A highly sensitive immuno-polymerase chain reaction assay for human angiotensinogen using the identical first and second polyclonal antibodies. Clin. Chim. Acta, 2000, 299, 45-54.
88. Lovrinovic, M.; Spengler, M.; Deutsch, C.; Niemeyer, C. M. Synthesis of covalent DNA-protein conjugates by expressed protein ligation. Mol. BioSyst., 2005, 1, 64-69.
89. Burbulis, I.; Yamaguchi, K.; Gordon, A.; Carlson, R.; Brent, R. Using protein-DNA chimeras to detect and count small numbers of molecules. Nat. Methods, 2005, 2, 31-37.
90. Finney, D.J. Statistical science and quantitative understanding. J. Toxicol. Sci., 1998, 23, 93-104.
91. FDA; CDER; CVM. Guidance for Industry: Bioanalytical Method Validation, 2001, pp. 1-22.
92. ICH. Validation of Analytical procedures: Text and Methodology Harmonised Tripartite Guideline, 2005, Q2(R1), http://www.fda.gov/cder/Guidance/1320fnl.pdf / http://www.fda.gov/cder/Guidance/ ichq1322a.pdf.
93. Niemeyer, C.M.; Wacker, R.; Adler, M. Combination of DNA-directed immobilization and immuno-PCR: very sensitive antigen detection by means of self-assembled DNA-protein conjugates. Nucleic Acids Res., 2003, 31, e90.
94. Niemeyer, C.M.; Adler, M.; Blohm, D. High Sensitivity Detection of Antigens using Immuno-PCR NUNC Tech Note, 1999, 5, 1-2.
95. Wang, T.W.; Lu, H.Y.; Lou, P.J.; Lin, F.H. Application of highly sensitive, modified glass substrate-based immuno-PCR on the early detection of nasopharyngeal carcinoma. Biomaterials, 2008, 29, 4447-4454.
96. Nam, J.M.; Thaxton, C.S.; Mirkin, C.A. Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science, 2003, 301, 1884-1886.
97. Adler, M.; Niemeyer, C.M. In DNA Amplification - Current Technologies and Applications, V.V. Demidov; Broude, N.E., eds.; Horizon Bioscience: Norfolk, 2004, 293-312.
98. Sims, P.W.; Vasser, M.; Wong, W.L.; Williams, P.M.; Meng, Y.G. Immunopolymerase chain reaction using real-time polymerase chain reaction for detection. Anal. Biochem., 2000, 281, 230-232.
99. Lind, K.; Kubista, M. Real-time Immuno-PCR on the iCycler iQ System. BioRadiations, 2002, 109, 32-33.
100. Hou, P.; Chen, Z.; Ji, M.; He, N.; Lu, Z. Real-time PCR assay for ultrasensitive quantification of DNA-binding proteins. Clin. Chem., 2007, 53, 581-586.
101. Rauch, P.; Polifke, T.; Wiesman, H.P. Hintergrund bei Immunoassays. Bioforum, 2005, 11, 22-24.
102. Selby, C. Interference in immunoassay. Ann. Clin. Biochem., 1999, 36 ( Pt 6), 704-721.
103. EDAR - New Bimoarkers for Alzheimer's Disease (European collaborative study) http://www.edarstudy.eu/, 2007, STREP 37670.
104. Jablonski, E.; Adams, T. The merging of nucleic acid detection and immunoassays. Medical Device, 2006, IVDT 2006, Available at: http://www.devicelink.com/ivdt/archive/06/11/009.html
105. Banin, S.; Wilson, S.M.; Stanley, C.J. Demonstration of an alternative approach to immuno-PCR. Clin. Chem., 2004, 50, 1932-1934.
106. Mairal, T.; Ozalp, V.C.; Lozano Sanchez, P.; Mir, M.; Katakis, I.; O'Sullivan, C.K. Aptamers: molecular tools for analytical applications. Anal. Bioanal. Chem., 2008, 390, 989-1007.
107. Bocci, V. Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review. J. Biol. Regul. Homeost. Agents., 1993, 7, 1-6.
108. Eck, J.; Langer, M.; Mockel, B.; Baur, A.; Rothe, M.; Zinke, H.; Lentzen, H. Cloning of the mistletoe lectin gene and characterization of the recombinant A-chain. Eur. J. Biochem., 1999, 264, 775-784.
109. Eck, J.; Langer, M.; Mockel, B.; Witthohn, K.; Zinke, H.; Lentzen, H. Characterization of recombinant and plant-derived mistletoe lectin and their B-chains. Eur. J. Biochem., 1999, 265, 788-797.
110. Wacker, R.; Spengler, M.; Adler, M. High sensitivity CNS biomarker detection 11th ICAD - International Conference of Alzheimer's Disease, Chicago July 26-31, 2008, P 1-400 / Abstract T336.
111. Sassolas, A.; Leca-Bouvier, B. D.; Blum, L. J. DNA biosensors and microarrays. Chem. Rev., 2008, 108, 109-139.
112. Niemeyer, C.M.; Blohm, D. DNA Microarrays. Angew. Chem. Int. Ed. Engl., 1999, 38, 2865-2869.
113. Spisak, S.; Tulassay, Z.; Molnar, B.; Guttman, A. Protein microchips in biomedicine and biomarker discovery. Electrophoresis, 2007, 28, 4261-4273.
114. Reid, J.D.; Parker, C.E.; Borchers, C.H. Protein arrays for biomarker discovery. Curr. Opin. Mol. Ther., 2007, 9, 216-221.
115. Hall, D.A.; Ptacek, J.; Snyder, M. Protein microarray technology. Mech. Ageing Dev., 2007, 128, 161-167.
116. Bozza, F.A.; Salluh, J.I.; Japiassu, A.M.; Soares, M.; Assis, E.F.; Gomes, R.N.; Bozza, M.T.; Castro-Faria-Neto, H.C.; Bozza, P.T. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit. Care., 2007, 11, R49.
117. Lagrelius, M.; Jones, P.; Franck, K.; Gaines, H. Cytokine detection by multiplex technology useful for assessing antigen specific cytokine profiles and kinetics in whole blood cultured up to seven days. Cytokine, 2006, 33, 156-165.
118. Sachdeva, N.; Asthana, D. Cytokine quantitation: technologies and applications. Front. Biosci., 2007, 12, 4682-4695.
119. Leng, S.X.; McElhaney, J.E.; Walston, J.D.; Xie, D.; Fedarko, N.S.; Kuchel, G.A. ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J. Gerontol. A Biol. Sci. Med. Sci., 2008, 63, 879-884.
120. Adler, M.; Niemeyer, C.M.; Stahl-Hennig, C.; Bodemer, W.; Blohm, D. Routinefähiges Immuno-PCR-Verfahren mit bis zu 1000-fach gesteigerter ELISA-Sensitivität. Poster annual meeting DECHEMA, Wiesbaden, 1999.
121. Wittwer, C.T.; Herrmann, M.G.; Gundry, C.N.; Elenitoba-Johnson, K.S. Real-time multiplex PCR assays. Methods, 2001, 25, 430-442.
122. Henegariu, O.; Heerema, N.A.; Dlouhy, S.R.; Vance, G.H.; Vogt, P.H. Multiplex PCR: critical parameters and step-by-step protocol. Biotechniques, 1997, 23, 504-511.
123. Lizardi, P.M.; Huang, X.; Zhu, Z.; Bray-Ward, P.; Thomas, D.C.; Ward, D.C. Mutation detection and single-molecule counting using isothermal rolling-circle amplification. Nat. Genet, 1998, 19, 225-232.
124. Schweitzer, B.; Wiltshire, S.; Lambert, J.; O'Malley, S.; Kukanskis, K.; Zhu, Z.; Kingsmore, S.F.; Lizardi, P.M.; Ward, D.C. Immunoassays with rolling circle DNA amplification: A versatile platform for ultrasensitive antigen detection. Proc. Natl. Acad. Sci. USA, 2000, 97, 10113-10119.
125. Schweitzer, B.; Roberts, S.; Grimwade, B.; Shao, W.; Wang, M.; Fu, Q.; Shu, Q.; Laroche, I.; Zhou, Z.; Tchernev, V. T.; Christiansen, J.; Velleca, M.; Kingsmore, S. F. Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat. Biotechnol., 2002, 20, 359-365.
126. Shao, W.; Zhou, Z.; Laroche, I.; Lu, H.; Zong, Q.; Patel, D.D.; Kingsmore, S.; Piccoli, S.P. Optimization of Rolling-Circle Amplified Protein Microarrays for Multiplexed Protein Profiling. J. Biomed. Biotechnol., 2003, 2003, 299-307.
127. Furuya, D.; Yagihashi, A.; Yajima, T.; Kobayashi, D.; Orita, K.; Kurimoto, M.; Watanabe, N. An immuno-polymerase chain reaction assay for human interleukin-18. J. Immunol. Methods, 2000, 238, 173-180.
128. Chang, B.; Cheng, X.; Yin, S.; Pan, T.; Zhang, H.; Wong, P.; Kang, S.C.; Xiao, F.; Yan, H.; Li, C.; Wolfe, L.L.; Miller, M.W.; Wisniewski, T.; Greene, M.I.; Sy, M.S. Test for detection of disease-associated prion aggregate in the blood of infected but asymptomatic animals. Clin. Vaccine. Immunol., 2007, 14, 36-43.
129. Gofflot, S.; Deprez, M.; el Moualij, B.; Osman, A.; Thonnart, J.F.; Hougrand, O.; Heinen, E.; Zorzi, W. Immunoquantitative PCR for prion protein detection in sporadic Creutzfeldt-Jakob disease. Clin. Chem., 2005, 51, 1605-1611.
130. König, C.; Engemann, C.; Krummrei, U.; Wacker, R.; Hoffmann, R. Highly sensitive detection of prions - new opportunities in the diagnosis of transmissible spongiform encephalopathies. Presentation during Prion2005 conference, 2005, Poster available online: http://priontype.com/files/Poster-Prion2005.Adobe5.0.pdf
131. Georganopoulou, D.G.; Chang, L.; Nam, J.M.; Thaxton, C.S.; Mufson, E.J.; Klein, W.L.; Mirkin, C.A. Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease. Proc. Natl. Acad. Sci. USA, 2005, 102, 2273-2276.
132. Azzazy, H.M.; Mansour, M.M.; Kazmierczak, S.C. Nanodiagnostics: a new frontier for clinical laboratory medicine. Clin. Chem., 2006, 52, 1238-1246.
133. Wacker, R.; Chalbot, S.; Schulz, S.; Grundke-Iqbal, I.; Iqbal, K.A. Quantitative real-time immuno-pcr to measure tau phosphorylated at serine 199 in cerebrospinal fluid 11th ICAD - International Conference of Alzheimer's Disease, Chicago July 26-31, 2008, Lecture.
134. Wacker, R.; Dyck, J.; Jonas, A.; Adler, M. Imperacer - new prospects in cns biomarker detection 8th international conference AD / PD Salzburg, Austria March 14-18, 2007, Poster.
135. Wacker, R.; Chalbot, S.; Schulz, S.; Grundke-Igbal, I.; Iqbal, K. A quantitative real-time Immuno-PCR to measure TAU phosphorylated at serine 199 in cerebospinal fluid 11th ICAD - International Conference of Alzheimer's Disease, Chicago July 26-31, 2008, Poster.
136. Kessler, M.; Goldsmith, D.; Schellekens, H. Immunogenicity of biopharmaceuticals. Nephrol. Dial. Transplant., 2006, 21(Suppl 5), v9-12.
137. Hill, H.D.; Mirkin, C.A. The bio-barcode assay for the detection of protein and nucleic acid targets using DTT-induced ligand exchange. Nat. Protoc., 2006, 1, 324-336.
138. Oh, B.K.; Nam, J.M.; Lee, S.W.; Mirkin, C.A. A fluorophore-based bio-barcode amplification assay for proteins. Small, 2006, 2, 103-108.
139. Tang, S.; Zhao, J.; Storhoff, J.J.; Norris, P.J.; Little, R.F.; Yarchoan, R.; Stramer, S.L.; Patno, T.; Domanus, M.; Dhar, A.; Mirkin, C.A.; Hewlett, I.K. Nanoparticle-Based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen. J. Acquir Immune. Defic. Syndr., 2007, 46, 231-237.
140. Spengler, U.; Laue, T. Das TaqMan-Prinzip. BioTec, 1998, 56-57.
141. Solinas, A.; Brown, L.J.; McKeen, C.; Mellor, J.M.; Nicol, J.; Thelwell, N.; Brown, T. Duplex Scorpion primers in SNP analysis and FRET applications. Nucleic Acids Res., 2001, 29, E96.
142. Carters, R.; Ferguson, J.; Gaut, R.; Ravetto, P.; Thelwell, N.; Whitcombe, D. Design and use of scorpions fluorescent signaling molecules. Methods Mol. Biol., 2008, 429, 99-115.
143. Di Marco, E.; Cangemi, G.; Filippetti, M.; Melioli, G.; Biassoni, R. Development and clinical validation of a real-time PCR using a uni-molecular Scorpion-based probe for the detection of Mycoplasma pneumoniae in clinical isolates. New Microbiol, 2007, 30, 415-421.
144. Lovrinovic, M.; Niemeyer, C.M. Rapid synthesis of DNA-cysteine conjugates for expressed protein ligation. Biochem. Biophys. Res. Commun., 2005, 335, 943-948.
145. Lovrinovic, M.; Niemeyer, C.M. Microtiter plate-based screening for the optimization of DNA-protein conjugate synthesis by means of expressed protein ligation. ChembioChem., 2007, 8, 61-67.